130 related articles for article (PubMed ID: 32574082)
1. Effect of
Mohammed ME; Abbas AM; Badi RM; Bashir SO; Osman OM; Morsy MD; Saeed AM
Arch Physiol Biochem; 2022 Dec; 128(6):1548-1558. PubMed ID: 32574082
[TBL] [Abstract][Full Text] [Related]
2. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
3. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
4. Biochanin-A has antidiabetic, antihyperlipidemic, antioxidant, and protective effects on diabetic nephropathy via suppression of TGF-β1 and PAR-2 genes expression in kidney tissues of STZ-induced diabetic rats.
Amri J; Alaee M; Babaei R; Salemi Z; Meshkani R; Ghazavi A; Akbari A; Salehi M
Biotechnol Appl Biochem; 2022 Oct; 69(5):2112-2121. PubMed ID: 34652037
[TBL] [Abstract][Full Text] [Related]
5. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.
Gu LY; Yun-Sun ; Tang HT; Xu ZX
J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats.
Anbar HS; Shehatou GS; Suddek GM; Gameil NM
Eur J Pharmacol; 2016 Jun; 780():82-92. PubMed ID: 27012991
[TBL] [Abstract][Full Text] [Related]
7. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.
Pang R; Gu D
Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721
[TBL] [Abstract][Full Text] [Related]
8. Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats.
Tian W; Lei H; Guan R; Xu Y; Li H; Wang L; Yang B; Gao Z; Xin Z
Drug Des Devel Ther; 2015; 9():5147-57. PubMed ID: 26379427
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional Suppression of Diabetic Nephropathy with Novel Gene Silencer Pyrrole-Imidazole Polyamides Preventing USF1 Binding to the TGF-β1 Promoter.
Okamura M; Fukuda N; Horikoshi S; Kobayashi H; Tsunemi A; Akiya Y; Endo M; Matsumoto T; Abe M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947045
[TBL] [Abstract][Full Text] [Related]
10. Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.
Huang J; Matavelli LC; Siragy HM
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):215-21. PubMed ID: 21265872
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta 1 in diabetic nephropathy.
Metwally SS; Mosaad YM; Nassr AA; Zaki OM
Egypt J Immunol; 2005; 12(1):103-12. PubMed ID: 16734145
[TBL] [Abstract][Full Text] [Related]
12. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes.
Chen J; Gu Y; Lin F; Yang H; Zhu W; Ma J; Lin S
Chin Med J (Engl); 2002 Jul; 115(7):972-8. PubMed ID: 12150723
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy.
Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R
Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017
[TBL] [Abstract][Full Text] [Related]
15. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E
J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
[TBL] [Abstract][Full Text] [Related]
17. [Effects of centella asiatica granule on the expression of TGF-β
Ma JW; Wang HT; Liu HF; Ding Y; Bai JQ; Zhang Z
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):69-73. PubMed ID: 29926663
[TBL] [Abstract][Full Text] [Related]
18. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanism of TGF-β1/SGK1 pathway in tubulointerstitial fibrosis of diabetic nephropathy.
Miao XJ; Bi TT; Tang JM; Lv R; Gui DK; Yang XF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10482-10488. PubMed ID: 31841202
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid attenuates type I diabetic nephropathy in rats.
Garud MS; Kulkarni YA
Chem Biol Interact; 2018 Feb; 282():69-76. PubMed ID: 29331653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
